. Ic-95%, mg), la valeur la plus basse était de 155 mg (5 ème palier), la plus élevée de 635 mg (8 ème soit le dernier palier) Chez les patients dont le test était négatif, la diminution moyenne du VEMS entre le VEMS de repos et celui de la dernière dose était de 5% (IC 95%, pp.322-588

W. Asthma, Rapport No.: Fact Sheet N°307 Disponible depuis : www.who.int/mediacentre, 2013.

A. Afrite, C. Allonier, L. Com-ruelle, L. Guen, and N. L. , asthme en France en 2006#: prévalence, contrôle et déterminants [Internet] Institut de recherche et documentation en économie de la santé, Jan. Rapport, 2011.

M. Delmas, C. Fuhrman, and . France, L???asthme en France??: synth??se des donn??es ??pid??miologiques descriptives, Revue des Maladies Respiratoires, vol.27, issue.2, pp.151-160, 2010.
DOI : 10.1016/j.rmr.2009.09.001

. Société-de-pneumologie-de-langue-française, Society for Pneumology in French Language. [Practice guidelines for Respiratory function tests 2008-2010]. Rev Mal Respir, pp.1183-92, 2011.

W. Busse, J. Corren, B. Lanier, M. Mcalary, A. Fowler-taylor et al., Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma, Journal of Allergy and Clinical Immunology, vol.108, issue.2, 2001.
DOI : 10.1067/mai.2001.117880

J. Corren, R. Lemanske, N. Hanania, P. Korenblat, M. Parsey et al., Lebrikizumab Treatment in Adults with Asthma, New England Journal of Medicine, vol.365, issue.12, pp.1088-98, 2011.
DOI : 10.1056/NEJMoa1106469

I. Pavord, S. Korn, P. Howarth, E. Bleecker, R. Buhl et al., Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial, The Lancet, vol.380, issue.9842, pp.651-660, 2012.
DOI : 10.1016/S0140-6736(12)60988-X

J. Derenne, T. Similowski, C. Straus, and M. Zelter, [The discovery of spirometry: back across the Channel], Rev Mal Respir, vol.20, issue.4, pp.633-637, 2003.

F. Kharfi, Instrumentation d'exploration fonctionelle

L. Delaunois and J. Delwiche, Exploration fonctionnelle respiratoire, EMC, 2005.
DOI : 10.1016/s1155-195x(05)28745-5

C. Schäper, S. Gläser, S. Felix, A. Gogolka, B. Koch et al., Omalizumab treatment and exercise capacity in severe asthmatics ??? Results from a pilot study, Respiratory Medicine, vol.105, issue.1, pp.3-7, 2011.
DOI : 10.1016/j.rmed.2010.07.023

A. Gicquello, Y a-t-il une place pour l???exploration ?? l???exercice chez l???asthmatique???, Thèse]. Université du droit et de la santé -Lille 2, 2013.
DOI : 10.1016/j.reval.2013.01.032

S. Moncada and A. Higgs, The L-arginine-nitric oxide pathway, N Engl J Med, vol.329, issue.27, pp.2002-2014, 1993.

A. Haccuria, A. Michils, S. Michiels, and A. Van-muylem, Exhaled nitric oxide: A??biomarker integrating both lung function and airway inflammation changes, Journal of Allergy and Clinical Immunology, vol.134, issue.3, pp.554-563, 2014.
DOI : 10.1016/j.jaci.2013.12.1070

S. Kharitonov, A. Wells, O. Connor, B. Cole, P. Hansell et al., Elevated levels of exhaled nitric oxide in bronchiectasis., American Journal of Respiratory and Critical Care Medicine, vol.151, issue.6, pp.1889-93, 1995.
DOI : 10.1164/ajrccm.151.6.7767536

W. Maziak, S. Loukides, S. Culpitt, P. Sullivan, S. Kharitonov et al., Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.3, pp.998-1002, 1998.
DOI : 10.1164/ajrccm.157.3.97-05009

J. Syk, A. Malinovschi, G. Johansson, A. Undén, A. Andreasson et al., Anti-inflammatory Treatment of Atopic Asthma Guided by Exhaled Nitric Oxide: A Randomized, Controlled Trial, The Journal of Allergy and Clinical Immunology: In Practice, vol.1, issue.6, 2013.
DOI : 10.1016/j.jaip.2013.07.013

R. Tiffeneau and M. Beauvallet, Epreuve de bronchoconstriction et de bronchodilatation par aerosols, Bull Acad Médecine, vol.2, pp.221-265, 1945.

P. Sterk, L. Fabbri, P. Quanjer, D. Cockcroft, O. Byrne et al., Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults Report Working Party Standardization of Lung Function Tests, Eur Respir J, vol.16, pp.53-83, 1993.

H. Chai, R. Farr, L. Froehlich, D. Mathison, J. Mclean et al., Standardization of bronchial inhalation challenge procedures, Journal of Allergy and Clinical Immunology, vol.56, issue.4, pp.323-330, 1975.
DOI : 10.1016/0091-6749(75)90107-4

D. Cockcroft, D. Killian, J. Mellon, and F. Hargreave, Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy, 1977.

D. Cockcroft, Direct Challenge Tests, Chest, vol.138, issue.2, pp.18-24, 2010.
DOI : 10.1378/chest.10-0088

D. Cockcroft, K. Murdock, B. Berscheid, and B. Gore, Sensitivity and specificity of histamine PC20 determination in a random selection of young college students*, Journal of Allergy and Clinical Immunology, vol.89, issue.1, pp.23-30, 1992.
DOI : 10.1016/S0091-6749(05)80037-5

R. Crapo, R. Casaburi, A. Coates, P. Enright, J. Hankinson et al., Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Am J Respir Crit Care Med, vol.161, issue.1, pp.309-338, 1999.

M. Silverman and S. Anderson, Standardization of Exercise Tests in Asthmatic Children, Archives of Disease in Childhood, vol.47, issue.256, pp.882-891, 1972.
DOI : 10.1136/adc.47.256.882

K. Rundell, S. Anderson, B. Spiering, and D. Judelson, Field Exercise vs Laboratory Eucapnic Voluntary Hyperventilation To Identify Airway Hyperresponsiveness in Elite Cold Weather Athletes, Chest, vol.125, issue.3, pp.909-924, 2004.
DOI : 10.1378/chest.125.3.909

M. Decramer, M. Demedts, and K. Van-de-woestijne, Isocapnic hyperventilation with cold air in healthy non-smokers, smokers and asthmatic subjects, Bull Eur Physiopathol Respir, vol.20, issue.3, pp.237-280, 1984.

C. Smith and S. Anderson, Inhalation provocation tests using nonisotonic aerosols, Journal of Allergy and Clinical Immunology, vol.84, issue.5, pp.781-90, 1989.
DOI : 10.1016/0091-6749(89)90309-6

C. Smith and S. Anderson, A comparison between the airway response to isocapnic hyperventilation and hypertonic saline in subjects with asthma, Eur Respir J, vol.2, issue.1, pp.36-43, 1989.

Z. Diamant, G. Gauvreau, D. Cockcroft, L. Boulet, P. Sterk et al., Inhaled allergen bronchoprovocation tests, Journal of Allergy and Clinical Immunology, vol.132, issue.5, pp.1045-55, 2013.
DOI : 10.1016/j.jaci.2013.08.023

A. Ravensberg, E. Van-rensen, D. Grootendorst, J. De-kluijver, Z. Diamant et al., Validated safety predictions of airway responses to house dust mite in asthma, Clinical & Experimental Allergy, vol.42, issue.50, 2007.
DOI : 10.1016/j.jaci.2004.03.034

D. Taylor, J. Harris, O. Connor, and B. , Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.22, issue.1, pp.56-63, 2000.
DOI : 10.1016/0140-6736(91)90277-V

E. Ihre and O. Zetterström, Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen, Clinical & Experimental Allergy, vol.19, issue.suppl 10, pp.298-305, 1993.
DOI : 10.1111/j.1365-2222.1993.tb00326.x

S. Anderson, J. Brannan, J. Spring, N. Spalding, L. Rodwell et al., A New Method For Bronchial-provocation Testing in Asthmatic Subjects Using a Dry Powder of Mannitol, American Journal of Respiratory and Critical Care Medicine, vol.156, issue.3, pp.758-65, 1997.
DOI : 10.1164/ajrccm.156.3.9701113

J. Brannan, S. Anderson, C. Perry, R. Freed-martens, A. Lassig et al., The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline, Respiratory Research, vol.143, issue.1, p.144, 2005.
DOI : 10.1201/b14271-12

A. Sverrild, C. Porsbjerg, S. Thomsen, and V. Backer, Diagnostic properties of inhaled mannitol in the diagnosis of asthma: A population study, Journal of Allergy and Clinical Immunology, vol.124, issue.5, pp.928-960, 2009.
DOI : 10.1016/j.jaci.2009.06.028

P. Quanjer, G. Tammeling, J. Cotes, O. Pedersen, R. Peslin et al., Lung volumes and forced ventilatory flows Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society, pp.5-40, 1993.

S. Anderson, B. Charlton, J. Weiler, S. Nichols, S. Spector et al., Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma, Respiratory Research, vol.117, issue.6, p.4, 2009.
DOI : 10.1016/j.jaci.2006.02.038

L. Wood, H. Powell, and P. Gibson, Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma, Clinical & Experimental Allergy, vol.40, issue.2, pp.232-273, 2010.
DOI : 10.1111/j.1365-2222.2009.03371.x

A. Sood, C. Qualls, M. Schuyler, A. Arynchyn, J. Alvarado et al., Adult-Onset Asthma Becomes the Dominant Phenotype among Women by Age 40 Years. The Longitudinal CARDIA Study, Annals of the American Thoracic Society, vol.10, issue.3, pp.188-97, 2013.
DOI : 10.1513/AnnalsATS.201212-115OC

J. Droste, M. Wieringa, J. Weyler, V. Nelen, V. Bever et al., Lung function measures and their relationship to respiratory symptoms in 7- and 8-year-old children, Pediatric Pulmonology, vol.48, issue.4, pp.260-266, 1999.
DOI : 10.1002/(SICI)1099-0496(199904)27:4<260::AID-PPUL6>3.0.CO;2-6

G. Marseglia, I. Cirillo, A. Vizzaccaro, C. Klersy, M. Tosca et al., Role of forced expiratory flow at 25???75% as an early marker of small airways impairment in subjects with allergic rhinitis, Allergy and Asthma Proceedings, vol.28, issue.1, pp.74-82, 2007.
DOI : 10.2500/aap.2007.28.2920

N. Bahçeciler, I. Barlan, $. Nuho, Y. Lu, and M. Ba&aran, Risk factors for the persistence of respiratory symptoms in childhood asthma. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol, pp.449-55, 2001.

T. Thongngarm, P. Silkoff, W. Kossack, and H. Nelson, Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma, J Asthma Off J Assoc Care Asthma, 2005.

G. Garcia, T. Perez, and B. Mahut, ??preuves fonctionnelles respiratoires et ??valuation des voies a??riennes distales dans l???asthme, Revue des Maladies Respiratoires, vol.26, issue.4, pp.395-406, 2009.
DOI : 10.1016/S0761-8425(09)74044-6

J. Hansen, X. Sun, and K. Wasserman, Discriminating Measures and Normal Values for Expiratory Obstruction, Chest, vol.129, issue.2, pp.369-77, 2006.
DOI : 10.1378/chest.129.2.369

K. Holzer, S. Anderson, H. Chan, and J. Douglass, Mannitol as a Challenge Test to Identify Exercise-induced Bronchoconstriction in Elite Athletes, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.4, pp.534-541, 2003.
DOI : 10.1164/rccm.200208-916OC

J. Brannan, H. Koskela, S. Anderson, and N. Chew, Responsiveness to Mannitol in Asthmatic Subjects with Exercise- and Hyperventilation-induced Asthma, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.4, pp.1120-1126, 1998.
DOI : 10.1164/ajrccm.158.4.9802087

P. Bordry, Délibération n°119 du 8 janvier 2009 Modifiant certaines modalités relatives aux documents médicaux devant être fournis à l'appui d'une demande d'autorisation d'usage à des fin thérapeutiques pour les pathologies asthmatiformes, 2009.

. Agence-mondiale-antidopage, Liste des interdiction 2014 standard international [Internet] Disponible depuis : http://list.wadaama .org/fr/files, 2013.

P. Kippelen, K. Fitch, S. Anderson, V. Bougault, L. Boulet et al., Respiratory health of elite athletes ??? preventing airway injury: a critical review, British Journal of Sports Medicine, vol.46, issue.7
DOI : 10.1136/bjsports-2012-091056

R. Irwin, F. Curley, and C. French, Chronic Cough: The Spectrum and Frequency of Causes, Key Components of the Diagnostic Evaluation, and Outcome of Specific Therapy, American Review of Respiratory Disease, vol.141, issue.3, pp.640-647, 1990.
DOI : 10.1164/ajrccm/141.3.640

H. Koskela, L. Hyvärinen, J. Brannan, H. Chan, and S. Anderson, Coughing during mannitol challenge is associated with asthma. Chest, 2004.

A. Singapuri, S. Mckenna, and C. Brightling, The utility of the mannitol challenge in the assessment of chronic cough: a pilot study, Cough, vol.4, issue.1, p.10, 2008.
DOI : 10.1186/1745-9974-4-10

S. Anderson, Indirect Challenge Tests, Chest, vol.138, issue.2, pp.25-30, 2010.
DOI : 10.1378/chest.10-0116

M. Perpiñá, C. Pellicer, A. De-diego, L. Compte, and V. Macián, Diagnostic Value of the Bronchial Provocation Test With Methacholine in Asthma, Chest, vol.104, issue.1, pp.149-54, 1993.
DOI : 10.1378/chest.104.1.149

D. Aronsson, E. Tufvesson, and L. Bjermer, Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics, The Clinical Respiratory Journal, vol.38, issue.1, pp.10-18, 2011.
DOI : 10.1111/j.1752-699X.2009.00183.x